Showing 1-10 of about 28 articles.
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced...
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced...
MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- 2020) – Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that...
MISONIX, Inc.
Full Year Revenue of Approximately $62.3 Million Company Focus on Shareholder Value Creation, Cash Preservation, Expense Reduction, Workforce Efficiency and Operational Synergies FARMINGDALE,...
MISONIX, Inc.
FARMINGDALE, N.Y., May 11, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
MISONIX, Inc.
With Focus on Maintaining Our Objective of Shareholder Value Creation, Company to Prioritize Cash Preservation Through Expense Reduction, Workforce Efficiency and Operational Synergies ...
MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
MicroCures, Inc.
$1 Million in Funding from the USAISR Supporting Collaborative Research Project Pilot Animal Study Successfully Completed; Larger Preclinical Study Underway NEW YORK, Jan. 28, 2020 (GLOBE...
MicroCures, Inc.
NEW YORK, Jan. 07, 2020 (GLOBE NEWSWIRE) -- MicroCures, a biopharmaceutical company developing novel therapeutics that harness the body’s innate regenerative mechanisms to accelerate tissue repair,...
MilanaPharm
TALLASSEE, Ala., May 09, 2019 (GLOBE NEWSWIRE) -- MilanaPharm, a specialty pharmaceutical company focused on the development of innovative, non-opioid pharmaceutical solutions for wound management...
Showing 1-10 of about 28 articles.
